Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

15.30
-0.5300-3.35%
Post-market: 15.400.1000+0.65%19:35 EDT
Volume:4.74M
Turnover:72.89M
Market Cap:3.08B
PE:-18.51
High:15.81
Open:15.81
Low:15.26
Close:15.83
52wk High:16.20
52wk Low:9.84
Shares:201.40M
Float Shares:195.63M
Volume Ratio:1.36
T/O Rate:2.42%
Dividend:1
Dividend Rate:6.54%
EPS(TTM):-0.8265
EPS(LYR):-1.4300
ROE:-4.86%
ROA:2.75%
PB:1.00
PE(LYR):-10.70

Loading ...

ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406

prnewswire
·
Apr 10

Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

GlobeNewswire
·
Apr 08

Comparison of Trading Platforms for Novice Fund Investors: Three Leading Apps Recommended

Deep News
·
Apr 08

Park Hotels & Resorts Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
Apr 07

Barclays Downgrades Park Hotels & Resorts to Equalweight From Overweight, Adjusts Price Target to $9 From $13

MT Newswires Live
·
Apr 07

Park Hotels & Resorts (PK) was downgraded to a Hold Rating at Barclays

TIPRANKS
·
Apr 07

JPMorgan vs. Goldman Sachs: Are Tariffs and Oil Prices a "Temporary Setback" or a "Long-Term Threat"?

Stock News
·
Apr 03

Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development

GlobeNewswire
·
Apr 02

Performance Comparison of Listed Rural Banks in Guangdong: Guangzhou Rural Commercial Stabilizes, Dongguan Rural Commercial Sees Third Consecutive Profit Decline

Deep News
·
Apr 01

DIARY-Federal Reserve Events

Reuters
·
Apr 01

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

GlobeNewswire
·
Mar 31

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

GlobeNewswire
·
Mar 31

Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

GlobeNewswire
·
Mar 30

Financial Showdown of Autonomous Driving Leaders: WeRide Burns Through 1.1 Billion More Than Pony.ai

Deep News
·
Mar 30

DIARY-Federal Reserve Events

Reuters
·
Mar 30

DIARY-Federal Reserve Events

Reuters
·
Mar 27

Park Hotels & Resorts Is Maintained at Hold by Truist Securities

Dow Jones
·
Mar 26

Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Dow Jones
·
Mar 26

Press Release: MetaVia Reports Year End 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 26

Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 26